This is a synthetic peptide designed for use in combination with anti-DGCR6 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
DGCR6
(DiGeorge Syndrome Critical Region Gene 6 (DGCR6))
Synonyme
AU044152 Peptide, DGCR6 Peptide, DKFZp459P114 Peptide, DGCR6L Peptide, zgc:101841 Peptide, DiGeorge syndrome critical region gene 6 Peptide, protein DGCR6 Peptide, DiGeorge syndrome critical region gene 6 S homeolog Peptide, DGCR6 Peptide, Dgcr6 Peptide, LOC458642 Peptide, dgcr6.S Peptide, dgcr6 Peptide
Hintergrund
DiGeorge syndrome, and more widely, the CATCH 22 syndrome, are associated with microdeletions in chromosomal region 22q11.2. The product of this gene shares homology with the Drosophila melanogaster gonadal protein, which participates in gonadal and germ cell development, and with the gamma-1 subunit of human laminin. This gene is a candidate for involvement in DiGeorge syndrome pathology and in schizophrenia.